Roche Holding AG RHHVF Stock
Roche Holding AG Price Chart
Roche Holding AG RHHVF Financial and Trading Overview
| Roche Holding AG stock price | 414.8 USD |
| Previous Close | 415 USD |
| Open | 411 USD |
| Bid | 398.62 USD x 5900 |
| Ask | 417 USD x 8100 |
| Day's Range | 411 - 411 USD |
| 52 Week Range | 300.15 - 490.33 USD |
| Volume | 45 USD |
| Avg. Volume | 4.32K USD |
| Market Cap | 330.62B USD |
| Beta (5Y Monthly) | 0.344 |
| PE Ratio (TTM) | 20.757576 |
| EPS (TTM) | 19.83 USD |
| Forward Dividend & Yield | 12.4 (2.95%) |
| Ex-Dividend Date | March 12, 2026 |
| 1y Target Est | 466.48 USD |
RHHVF Valuation Measures
| Enterprise Value | 355.57B USD |
| Trailing P/E | 20.757576 |
| Forward P/E | 16.005669 |
| PEG Ratio (5 yr expected) | 1.49 |
| Price/Sales (ttm) | 5.2183876 |
| Price/Book (mrq) | 7.8245835 |
| Enterprise Value/Revenue | 5.612 |
| Enterprise Value/EBITDA | 14.788 |
Trading Information
Roche Holding AG Stock Price History
| Beta (5Y Monthly) | 0.344 |
| 52-Week Change | 30.68% |
| S&P500 52-Week Change | 20.84% |
| 52 Week High | 490.33 USD |
| 52 Week Low | 300.15 USD |
| 50-Day Moving Average | 408.37 USD |
| 200-Day Moving Average | 402.27 USD |
RHHVF Share Statistics
| Avg. Volume (3 month) | 4.32K USD |
| Avg. Daily Volume (10-Days) | 610 USD |
| Shares Outstanding | 688.93M |
| Float | 652.94M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 43.96% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 9.8 |
| Trailing Annual Dividend Yield | 2.36% |
| 5 Year Average Dividend Yield | 323.00% |
| Payout Ratio | 0.6047 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 20.33% |
| Operating Margin (ttm) | 29.98% |
| Gross Margin | 74.48% |
| EBITDA Margin | 37.95% |
Management Effectiveness
| Return on Assets (ttm) | 12.93% |
| Return on Equity (ttm) | 37.27% |
Income Statement
| Revenue (ttm) | 63.36B USD |
| Revenue Per Share (ttm) | 79.59 USD |
| Quarterly Revenue Growth (yoy) | -0.40% |
| Gross Profit (ttm) | 47.19B USD |
| EBITDA | 24.04B USD |
| Net Income Avi to Common (ttm) | 12.88B USD |
| Diluted EPS (ttm) | 19.8 |
| Quarterly Earnings Growth (yoy) | 170.90% |
Balance Sheet
| Total Cash (mrq) | 15.49B USD |
| Total Cash Per Share (mrq) | 19.46 USD |
| Total Debt (mrq) | 33.2B USD |
| Total Debt/Equity (mrq) | 87.64 USD |
| Current Ratio (mrq) | 1.383 |
| Book Value Per Share (mrq) | 52.526756 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 18.85B USD |
| Levered Free Cash Flow (ttm) | 11.03B USD |
Profile of Roche Holding AG
| Country | United States |
| State | N/A |
| City | Basel |
| Address | Grenzacherstrasse 124 |
| ZIP | 4070 |
| Phone | 41 61 688 88 80 |
| Website | https://www.roche.com |
| Industry | Drug Manufacturers - General |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. Roche Holding AG has a collaboration agreement with Excalipoint Therapeutics to evaluate EXP011 in DLL3-expressing solid tumors. The company was founded in 1896 and is based in Basel, Switzerland.
Q&A For Roche Holding AG Stock
What is a current RHHVF stock price?
Roche Holding AG RHHVF stock price today per share is 414.8 USD.
How to purchase Roche Holding AG stock?
You can buy RHHVF shares on the OTC Markets OTCQX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Roche Holding AG?
The stock symbol or ticker of Roche Holding AG is RHHVF.
Which industry does the Roche Holding AG company belong to?
The Roche Holding AG industry is Drug Manufacturers - General.
How many shares does Roche Holding AG have in circulation?
The max supply of Roche Holding AG shares is 804.42M.
What is Roche Holding AG Price to Earnings Ratio (PE Ratio)?
Roche Holding AG PE Ratio is 20.91780000 now.
What was Roche Holding AG earnings per share over the trailing 12 months (TTM)?
Roche Holding AG EPS is 19.83 USD over the trailing 12 months.
Which sector does the Roche Holding AG company belong to?
The Roche Holding AG sector is Healthcare.